News
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Gilead Sciences, Inc. ("Gilead" or "the Company") (NASDAQ: GILD) ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE ...
Researchers reveal how activating the Egr-1 gene can help alleviate autoimmune inflammation via Foxp3 expression Autoimmune ...
A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer.
14h
AllAfrica on MSNTB's Tight Grip - Why This Curable Disease Is So Hard to TreatTB can be cured, but ridding the body of the bug often takes many months and usually requires taking four or more different medicines. In this Spotlight special briefing, we zoom in on what makes the ...
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
In order to produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results